Literature DB >> 9109944

Characterization of a human myxoid malignant fibrous histiocytoma cell line, OH931.

A K Krause1, S H Hinrichs, C Orndal, J DeBoer, J R Neff, J A Bridge.   

Abstract

Malignant fibrous histiocytoma (MFH), the most common soft-tissue sarcoma of late adult life, includes several histopathologic subtypes. The myxoid MFH subtype is characterized by the presence of abundant mucopolysaccharide within a loose connective tissue stroma. Although the myxoid variant is typically distinguished clinically by its better prognosis, we report a case of myxoid MFH that exhibited an aggressive phenotype with early metastases and death. A cell line, OH931, was established from this myxoid MFH. The primary tumor, OH931 cell line, and cells recovered from tumors generated in nude mice shared similar morphologic features, including the continued production of abundant mucopolysaccharide. Cytogenetic analysis of the primary tumor and a subsequently established cell line (OH931) revealed a complex hypertriploid mainline. Chromosomal breakpoints involved in all three specimens analyzed (diagnostic biopsy, definitive surgical, and cell line) included 1p33, 1q21, 2p14, 4p15, 5q13, 12q13, 14p13, 15p13, 19q13 and 20q13.1. The OH931 cell line, which appears to maintain its peculiar characteristics in vitro, should be useful in studies investigating the role of mucopolysaccharide production in the process of neoplasia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9109944     DOI: 10.1016/s0165-4608(96)00223-3

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  6 in total

1.  Establishment of a new human pleomorphic malignant fibrous histiocytoma cell line, FU-MFH-2: molecular cytogenetic characterization by multicolor fluorescence in situ hybridization and comparative genomic hybridization.

Authors:  Jun Nishio; Hiroshi Iwasaki; Kazuki Nabeshima; Masako Ishiguro; Teruto Isayama; Masatoshi Naito
Journal:  J Exp Clin Cancer Res       Date:  2010-11-24

2.  Xenograft models for undifferentiated pleomorphic sarcoma not otherwise specified are essential for preclinical testing of therapeutic agents.

Authors:  Marc Becker; Claudine Graf; Marcus Tonak; Markus P Radsak; Tobias Bopp; Robert Bals; Rainer M Bohle; Matthias Theobald; Pol-Maria Rommens; Dirk Proschek; Thomas C Wehler
Journal:  Oncol Lett       Date:  2016-06-24       Impact factor: 2.967

3.  Establishment of a nude mouse transplantable model of a human malignant fibrous histiocytoma of the mandible with high metastatic potential to the lung.

Authors:  Tsunenari Maeda; Susumu Hashitani; Yusuke Zushi; Emi Segawa; Noriaki Tanaka; Kazunari Sakurai; Masahiro Urade
Journal:  J Cancer Res Clin Oncol       Date:  2008-03-04       Impact factor: 4.553

4.  A Functional Precision Oncology Approach to Identify Treatment Strategies for Myxofibrosarcoma Patients.

Authors:  Benjamin D Hopkins; Mark A Rubin; Chantal Pauli; Lamberto De Boni; Jonathan E Pauwels; Yanjiang Chen; Lara Planas-Paz; Reid Shaw; Brooke M Emerling; Carla Grandori
Journal:  Mol Cancer Res       Date:  2021-11-02       Impact factor: 5.852

5.  PI5P4Ks drive metabolic homeostasis through peroxisome-mitochondria interplay.

Authors:  Archna Ravi; Lavinia Palamiuc; Ryan M Loughran; Joanna Triscott; Gurpreet K Arora; Avi Kumar; Vivian Tieu; Chantal Pauli; Matthias Reist; Rachel J Lew; Shauna L Houlihan; Christof Fellmann; Christian Metallo; Mark A Rubin; Brooke M Emerling
Journal:  Dev Cell       Date:  2021-05-12       Impact factor: 13.417

Review 6.  Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives.

Authors:  Silvia Vanni; Alessandro De Vita; Lorena Gurrieri; Valentina Fausti; Giacomo Miserocchi; Chiara Spadazzi; Chiara Liverani; Claudia Cocchi; Chiara Calabrese; Alberto Bongiovanni; Nada Riva; Laura Mercatali; Federica Pieri; Roberto Casadei; Enrico Lucarelli; Toni Ibrahim
Journal:  Ther Adv Med Oncol       Date:  2022-06-28       Impact factor: 5.485

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.